These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17431751)

  • 1. Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs.
    Willmann S; Höhn K; Edginton A; Sevestre M; Solodenko J; Weiss W; Lippert J; Schmitt W
    J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3):401-31. PubMed ID: 17431751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
    Edginton AN; Schmitt W; Willmann S
    Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-Related Changes in Pediatric Physiology: Quantitative Analysis of Organ Weights and Blood Flows : Age-Related Changes in Pediatric Physiology.
    Chang HP; Kim SJ; Wu D; Shah K; Shah DK
    AAPS J; 2021 Mar; 23(3):50. PubMed ID: 33791883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations.
    Krauss M; Tappe K; Schuppert A; Kuepfer L; Goerlitz L
    PLoS One; 2015; 10(10):e0139423. PubMed ID: 26431198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years.
    Edginton AN; Shah B; Sevestre M; Momper JD
    Clin Pharmacokinet; 2013 Aug; 52(8):693-703. PubMed ID: 23588537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulation of differential drug pharmacokinetics under heat and exercise stress using a physiologically based pharmacokinetic modeling approach.
    Sidhu P; Peng HT; Cheung B; Edginton A
    Can J Physiol Pharmacol; 2011 May; 89(5):365-82. PubMed ID: 21627485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal fat mass cannot be reliably estimated in typical pharmacokinetic studies.
    Wasmann RE; Svensson EM; Schalkwijk SJ; Brüggemann RJ; Ter Heine R
    Eur J Clin Pharmacol; 2021 May; 77(5):727-733. PubMed ID: 33205282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.
    Graf JF; Scholz BJ; Zavodszky MI
    J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):37-54. PubMed ID: 22161221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling.
    Upton RN
    J Pharmacol Toxicol Methods; 2008; 58(3):198-205. PubMed ID: 18775498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
    Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
    Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.
    Peters SA
    Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds.
    Yun YE; Edginton AN
    J Toxicol Environ Health A; 2019; 82(14):789-814. PubMed ID: 31405354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals.
    Berton M; Bettonte S; Stader F; Battegay M; Marzolini C
    Clin Pharmacokinet; 2023 Feb; 62(2):277-295. PubMed ID: 36571702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Ciprofloxacin Pharmacokinetics in Healthy Mexican Volunteers and Other Populations: Is There Interethnic Variability?
    Tolentino-Hernández SJ; Cruz-Antonio L; Pérez-Urizar J; Cabrera-Fuentes HA; Castañeda-Hernández G
    Arch Med Res; 2020 Apr; 51(3):268-277. PubMed ID: 32143939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly.
    Thompson CM; Johns DO; Sonawane B; Barton HA; Hattis D; Tardif R; Krishnan K
    J Toxicol Environ Health B Crit Rev; 2009 Jan; 12(1):1-24. PubMed ID: 19117207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles.
    Peters SA
    Clin Pharmacokinet; 2008; 47(4):245-59. PubMed ID: 18336054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthropometric models of bone mineral content and areal bone mineral density based on the bone mineral density in childhood study.
    Short DF; Gilsanz V; Kalkwarf HJ; Lappe JM; Oberfield S; Shepherd JA; Winer KK; Zemel BS; Hangartner TN
    Osteoporos Int; 2015 Mar; 26(3):1099-108. PubMed ID: 25311106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.